Global Health Initiatives Market Outlook

According to our latest research, the global health initiatives market size reached USD 56.7 billion in 2024, demonstrating robust expansion driven by increased global health spending and cross-sector collaborations. The market is projected to grow at a CAGR of 7.4% from 2025 to 2033, reaching an estimated USD 107.5 billion by 2033. This growth is primarily attributed to heightened international focus on disease prevention, health system strengthening, and the scaling up of innovative healthcare delivery models, as well as the rising prevalence of chronic and infectious diseases worldwide.

A key growth factor for the global health initiatives market is the increasing prioritization of public health in governmental and multilateral agendas. The COVID-19 pandemic has significantly shifted the global discourse toward health security, leading to a surge in funding for both disease-specific programs and broader health system strengthening. Governments and international organizations are now more focused than ever on building resilient health systems capable of responding to future pandemics and health crises. This renewed attention has resulted in substantial investments in surveillance, early warning systems, and emergency preparedness, which are all critical components of global health initiatives. Such investments are expected to have a lasting impact, driving both immediate and long-term market growth.

Another vital factor fueling market expansion is the growing involvement of the private sector and non-governmental organizations (NGOs) in health initiatives. With traditional funding sources facing constraints, private philanthropy and public-private partnerships are increasingly bridging the gap, enabling the implementation of large-scale, high-impact health programs. Tech companies, pharmaceutical firms, and financial institutions are collaborating to introduce digital health solutions, innovative financing mechanisms, and capacity-building projects, particularly in low- and middle-income countries. These collaborations are not only expanding the reach of health interventions but also enhancing their efficiency and sustainability, thereby contributing to the overall growth of the global health initiatives market.

Additionally, the market is being propelled by the rising demand for targeted interventions addressing maternal and child health, nutrition, and immunization. The persistent burden of preventable diseases, malnutrition, and inequities in healthcare access have prompted international stakeholders to prioritize these areas. Global initiatives such as Gavi, the Vaccine Alliance, and the Global Fund to Fight AIDS, Tuberculosis and Malaria are channeling resources into immunization campaigns, nutrition supplementation, and maternal care programs. The increasing adoption of evidence-based strategies, community engagement, and technology-driven outreach is further amplifying the impact of these initiatives, solidifying their role as key drivers of market growth.

From a regional perspective, the Asia Pacific and Sub-Saharan Africa regions continue to dominate the global health initiatives market, accounting for the largest share of both funding and programmatic activities. These regions face significant health challenges, including high disease burdens, rapidly growing populations, and limited healthcare infrastructure. As a result, they attract substantial investments from multilateral organizations, donor governments, and private foundations. However, North America and Europe are also witnessing increased activity, particularly in areas related to health system strengthening, digital health integration, and policy advocacy. The regional diversification of health initiatives underscores the global nature of the market and highlights the need for context-specific approaches to maximize impact.

Program Type Analysis

The global health initiatives market is segmented by program type into disease-specific initiatives, health system strengthening, maternal and child health, immunization, n

In 2023, Singapore ranked first with a health index score of ****, followed by Japan and South Korea. The health index measures the extent to which people are healthy and have access to the necessary services to maintain good health, including health outcomes, health systems, illness and risk factors, and mortality rates. The statistic shows the health and health systems ranking of countries worldwide in 2023, by their health index score.

A survey of people from 31 different countries around the world found that mental health was the biggest health problem respondents said was facing their country in 2024. Other health problems reported by respondents included cancer, stress, and obesity. The COVID-19 pandemic The COVID-19 pandemic impacted almost every country in the world and was the biggest global health crisis in recent history. It resulted in hundreds of millions of cases and millions of deaths, causing unprecedented disruption in health care systems. Lockdowns imposed in many countries to halt the spread of the virus also resulted in a rise of mental health issues as feelings of stress, isolation, and hopelessness arose. However, vaccines to combat the virus were developed at record speed, and many countries have now vaccinated large shares of their population. Nevertheless, in 2024, ** percent of respondents still stated that COVID-19 was the biggest health problem facing their country. Mental health issues One side effect of the COVID-19 pandemic has been a focus on mental health around the world. The two most common mental health issues worldwide are anxiety disorders and depression. In 2021, it was estimated that around *** percent of the global population had an anxiety disorder, while **** percent suffered from depression. Rates of depression are higher among females than males, with some *** percent of females suffering from depression, compared to *** percent of men. However, rates of suicide in most countries are higher among men than women. One positive outcome of the COVID-19 pandemic and the spotlight it shined on mental health may be a decrease in stigma surrounding mental health issues and seeking help for such issues. This would be a positive development as many people around the world do not or cannot receive the necessary treatment they need for their mental health.

The healthcare ranking reflects the quality of health care and access to health services in different countries. The assessment includes various factors such as life expectancy, access to medical services, healthcare funding, and technologies.

It was estimated that in 2023, around 10.8 million people worldwide developed tuberculosis. That same year, there were around 384,785 cases of mumps. This statistic depicts the number of reported cases of selected infectious diseases worldwide in 2023.

Global Health Perceived as Good or Very Good Among Persons Aged 15+ from the Highest Income Quintile by Country, 2023 Discover more data with ReportLinker!

In 2022, the Global Fund to Fight AIDS, Tuberculosis and Malaria, or simply the Global Fund, was the leading recipient of official development assistance for global health from the United States. That year the United States donated around 3.1 billion U.S. dollars to the Global Fund. The U.S. also gave around 267.7 million dollars to the World Health Organization (WHO), however this was only assessed contributions, with the majority of U.S. donations to the WHO being voluntary contributions.

Changelog:

Update September 20, 2021: Data and overview updated to reflect data used in the September 15 story Over Half of States Have Rolled Back Public Health Powers in Pandemic. It includes 303 state or local public health leaders who resigned, retired or were fired between April 1, 2020 and Sept. 12, 2021. Previous versions of this dataset reflected data used in the Dec. 2020 and April 2021 stories.

Overview

Across the U.S., state and local public health officials have found themselves at the center of a political storm as they combat the worst pandemic in a century. Amid a fractured federal response, the usually invisible army of workers charged with preventing the spread of infectious disease has become a public punching bag.

In the midst of the coronavirus pandemic, at least 303 state or local public health leaders in 41 states have resigned, retired or been fired since April 1, 2020, according to an ongoing investigation by The Associated Press and KHN.

According to experts, that is the largest exodus of public health leaders in American history.

Many left due to political blowback or pandemic pressure, as they became the target of groups that have coalesced around a common goal — fighting and even threatening officials over mask orders and well-established public health activities like quarantines and contact tracing. Some left to take higher profile positions, or due to health concerns. Others were fired for poor performance. Dozens retired. An untold number of lower level staffers have also left.

The result is a further erosion of the nation’s already fragile public health infrastructure, which KHN and the AP documented beginning in 2020 in the Underfunded and Under Threat project.

Findings

The AP and KHN found that:

• One in five Americans live in a community that has lost its local public health department leader during the pandemic
• Top public health officials in 28 states have left state-level departments ## Using this data To filter for data specific to your state, use this query

To get total numbers of exits by state, broken down by state and local departments, use this query

Methodology

KHN and AP counted how many state and local public health leaders have left their jobs between April 1, 2020 and Sept. 12, 2021.

The government tasks public health workers with improving the health of the general population, through their work to encourage healthy living and prevent infectious disease. To that end, public health officials do everything from inspecting water and food safety to testing the nation’s babies for metabolic diseases and contact tracing cases of syphilis.

Many parts of the country have a health officer and a health director/administrator by statute. The analysis counted both of those positions if they existed. For state-level departments, the count tracks people in the top and second-highest-ranking job.

The analysis includes exits of top department officials regardless of reason, because no matter the reason, each left a vacancy at the top of a health agency during the pandemic. Reasons for departures include political pressure, health concerns and poor performance. Others left to take higher profile positions or to retire. Some departments had multiple top officials exit over the course of the pandemic; each is included in the analysis.

Reporters compiled the exit list by reaching out to public health associations and experts in every state and interviewing hundreds of public health employees. They also received information from the National Association of City and County Health Officials, and combed news reports and records.

Public health departments can be found at multiple levels of government. Each state has a department that handles these tasks, but most states also have local departments that either operate under local or state control. The population served by each local health department is calculated using the U.S. Census Bureau 2019 Population Estimates based on each department’s jurisdiction.

KHN and the AP have worked since the spring on a series of stories documenting the funding, staffing and problems around public health. A previous data distribution detailed a decade's worth of cuts to state and local spending and staffing on public health. That data can be found here.

Attribution

Findings and the data should be cited as: "According to a KHN and Associated Press report."

Is Data Missing?

If you know of a public health official in your state or area who has left that position between April 1, 2020 and Sept. 12, 2021 and isn't currently in our dataset, please contact authors Anna Maria Barry-Jester annab@kff.org, Hannah Recht hrecht@kff.org, Michelle Smith mrsmith@ap.org and Lauren Weber laurenw@kff.org.

BackgroundUniversities undertake the majority of publicly funded research in Germany and hence bear a responsibility to contribute to global health efforts. So far, involvement and impact of German medical faculties in global health are unknown. Our aim was to systematically asses and evaluate German medical faculties’ contribution to global health related research and education, as well as their policies and practices concerning open access publishing and equitable licensing.MethodsWe assessed the involvement in global health of all 36 publicly funded medical faculties in Germany during 2010–2014 in three areas: innovation, access and education, using the following indicators: research funding and publications focused on global health or poverty-related and neglected diseases; open access publishing and policies promoting access to medical innovations worldwide; provision of global health education. Data were gathered from public databases, university websites and questionnaires sent to individual universities for validation and triangulation.ResultsThere was a high level of variability between institutions and indicators. The proportion of research funding for poverty-related and neglected diseases research ranged between 0.0–1.1%. The top five institutions received nearly 85% of the total poverty-related and neglected diseases research funding. 20 of 36 universities had an institutional open access publishing policy, 19 had an open access publishing fund, 16 had neither. Only one university reported having used an equitable licensing policy. 22 of 36 faculties provided some global health education, but only one of them included global health in their core undergraduate medical curriculum as a compulsory course with more than just single lectures.ConclusionObtained data indicate that global health and poverty-related and neglected diseases research at German medical faculties is highly concentrated in a few institutions, open-access publishing and equitable licensing policies are mostly absent, and only little global health education exists. Universities and government should address global health strategically in both research and education at medical faculties to reflect the country’s economic and political weight and human resource potential.

Top 15 science agencies funding global health R&D (2013).

Global Total Number of 10% Top-Cited Scientific Publications in Public Health, Environmental and Occupational Health by Country, 2023 Discover more data with ReportLinker!

This report lists the Top 50 global health & beauty retailers by consumer expenditure, which includes sales tax, for the 2017 calendar year, so company data and market shares are comparable. These include retailers operating across formats. Read More

As seen in the graph, there has been a sharp decline in the number of reported cases of both measles and pertussis (whooping cough) since 1980 as a result of vaccines. This statistic shows the number of reported cases of selected vaccine-preventable diseases worldwide, from 1980 to 2023, by disease.

According to Cognitive Market Research, Health Insurance Market Size was USD XX Million in 2025 and is set to achieve a market size of USD XX Million by the end of 2033 growing at a CAGR of XX% from 2025 to 2033.

North America region dominated the market and accounted for the highest revenue of XX% in 2024
Europe held share of xx% in the year 2024 
Asia-Pacific held significant share of xx% in the year 2024 
South America held significant share of xx% in the year 2024
Middle East and Africa held significant share of xx% in the year 2024 

Market Dynamics of Health Insurance Market

Key Drivers of Health Insurance Market

Rising Chronic Diseases Boosting the Health Insurance Market growth

The rising prevalence of chronic illnesses such as cancer, diabetes, heart disease, and stroke is significantly propelling the health insurance market. In the US alone, 1.7 million people are diagnosed with cancer annually. Over 38 million US adults suffer from diabetes, while nearly 100 million more have prediabetes, leading to greater demand for routine medical care and insurance coverage. Cardiovascular disease and stroke alone kill approximately 945,000 individuals each year with the healthcare system losing $254 billion annually and productivity worth $168 billion. These chronic conditions drive recurring healthcare needs, thereby making the need for health insurance products to absorb medical bills incurred earlier greater. Rising demand from chronic diseases and climbing healthcare costs is a decisive force on the global health insurance industry. Health insurance market growth is happening at a rapid rate in North America, where prevalence is high due to advanced healthcare infrastructure and greater awareness of insurance benefits. This trend points to the necessity of health insurance in protecting people against poverty and enabling access to treatment in the context of the increasing burden of chronic conditions worldwide.

Government Initiatives and Regulations

Government regulations such as the Affordable Care Act (ACA) in the U.S. and similar policies worldwide are driving health insurance enrollment by making insurance more accessible and affordable, often with subsidies and mandates for coverage.

Aging Population

The global aging population is one of the main drivers for health insurance as older individuals typically face higher healthcare needs, prompting a surge in demand for comprehensive health coverage.

Key Restraints of Health Insurance Market

Rising insurance premiums to hamper the health insurance market growth

The increasing cost of insurance premium particularly for chronic diseases is suppressing the development of the health insurance market. This is due to inflation raises the general cost of healthcare services like hospital stays, medical treatment, prescription drugs, and healthcare professionals' wages. For 2025, insurers have asked for an average premium increase of about 7%, largely driven by medical inflation that is higher than general economic inflation. Healthcare costs, especially hospital prices, have risen due to factors like hospital consolidation-which reduced competition-and workforce shortages that raise operating expenses. Additionally, the growing use of high-priced specialty drugs further boosts insurers' costs. Because insurers must cover these higher medical expenses, they pass on the greater expense to consumers in the form of higher premiums. For example, hospital systems have requested double-digit annual price increases, and the price of diagnostic and surgical procedures has soared over the past few years. Inflation also affects administrative and operational costs for insurers, which leads to premium hikes. From the consumer perspective, higher premiums reduce affordability, making health insurance harder to buy or maintain for individuals and families-especially those with low and moderate incomes. Unaffordable premiums discourage healthy individuals from enrolling, shrinking the risk pool and triggering further premium hikes, creating a cycle that destabilizes the market. Employers also face higher costs, which can translate into reduced benefits or a shift toward part-time work without insurance. Briefly, inflationary increases in healthcare costs directly elevate the premiums of health insurance, limiting access and affordability.

(Source:https://www.pwc.com/us/en/industries/health-indus...

Note: This dataset is historical only and there are not corresponding datasets for more recent time periods. For that more-recent information, please visit the Chicago Health Atlas at https://chicagohealthatlas.org.

This dataset contains the cumulative number of deaths, average number of deaths annually, average annual crude and adjusted death rates with corresponding 95% confidence intervals, and average annual years of potential life lost per 100,000 residents aged 75 and younger due to selected causes of death, by Chicago community area, for the years 2006 – 2010. A ranking for each measure is also provided, with the highest value indicated with a ranking of 1. See the full description at: https://data.cityofchicago.org/api/views/6vw3-8p6f/files/CqPqfHSv8UUAoXCBjn4_tLqcQHhb36Ih4-meM-4zNzs?download=true&filename=P:\EPI\OEPHI\MATERIALS\REFERENCES\MORTALITY\Dataset_Description_06_10_PORTAL_ONLY.pdf

In 2021, Mexico was the Latin American country with the highest overall Global Health Security (GHS) Index score, with 57 points out of a total of 100. In comparison, the United States, the best-rated country worldwide, had a score of 75.9. The Global Health Security Index measures a country's readiness to prevent, detect and respond to biological threats.

Tables containing information about research questions and teams. Table of contents: Top 10 Research Questions in Each Team. Table S1. Top 10 Research Questions in Disease Burden, Aetiology & Distribution. Table S2. Top 10 Research Questions in Nutrition & Long-Term Outcomes. Table S3. Top 10 Research Questions in Preventive Nutrition Strategies. Table S4. Top 10 Research Questions in Diagnostics. Table S5. Top 10 Research Questions in Vaccines for Diarrhoeal Prevention. Table S6. Top 10 Research Questions in WASH Interventions. Table S7. Top 10 Research Questions in Case Management. Table S8. Top 10 Research Questions in Emerging Interventions. Table S9. Top 10 Research Questions in Other Innovations. Table S10. Top 10 Research Questions in Monitoring & Evaluation. Top Twenty Research Questions By D4 Category. Table S11. Top 20 Research Questions in Description. Table S12. Top 20 Research Questions in Discovery. Table S13. Top 20 Research Questions in Development. Table S14. Top 20 Research Questions in Delivery. Table S15. All Research Questions. Table S16. Team Composition, Including Team Leaders, Participants, Countries Represented, and Institutional Affiliations. Table S17. Description of Standard CHNRI Criteria. Table S18. Description of CHNRI Criteria for Monitoring and Evaluation team. (DOCX)

Note: This dataset is historical only and there are not corresponding datasets for more recent time periods. For that more-recent information, please visit the Chicago Health Atlas at https://chicagohealthatlas.org.

This dataset contains a selection of 27 indicators of public health significance by Chicago community area, with the most updated information available. The indicators are rates, percents, or other measures related to natality, mortality, infectious disease, lead poisoning, and economic status. See the full description at https://data.cityofchicago.org/api/assets/2107948F-357D-4ED7-ACC2-2E9266BBFFA2.

Deaths covering Smoking only to 2019.

Health indicators are quantifiable characteristics of a population which researchers use as supporting evidence for describing the health of a population. The researchers use a survey methodology to gather information about certain people, use statistics in an attempt to generalize the information collected to the entire population, then use the statistical analysis to make a statement about the health of a population. Health indicators are often used by governments to guide health care policy.